XML 41 R21.htm IDEA: XBRL DOCUMENT
v3.25.1

GOODWILL AND INTANGIBLE ASSETS | 3 Months Ended
--- | ---
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND INTANGIBLE ASSETS The Company’s policy is to assess goodwill and indefinite-lived intangible assets for impairment annually as of April 1, with more frequent assessments if events or changes in circumstances indicate the asset might be impaired. Impairment charges are recorded in Goodwill and intangible asset impairment in the Consolidated Statement of Operations. For the three months ended March 31, 2025, the Company considered qualitative and quantitative factors to determine whether any events or changes in circumstances had resulted in a more likely than not impairment of any of its goodwill or indefinite-lived intangible assets during the course of the quarter, and concluded there were no such indicators. Impairment during the Three Months Ended March 31, 2024 In the three months ended March 31, 2024, the Company identified indicators of a more likely than not impairment related to certain indefinite-lived imaging product trade names within the Connected Technology Solutions segment. The decline in fair value of these indefinite-lived trade names was driven by declines in volumes during the three months ended March 31, 2024, which was due in part to a loss in market share from competitive pricing pressures, as well as unfavorable economic conditions in certain markets. These factors contributed to a reduction in forecasted revenues in the near term. The trade names were evaluated for impairment using an income approach, specifically a relief from royalty method. As a result, the Company recorded an indefinite-lived intangible asset impairment charge of $6 million for the three months ended March 31, 2024.
A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:
(in millions) |  |  |  |  |  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total
Balance at December 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  | $ | 291 |  |  | $ | 829 |  |  | $ | 1,276 |  |  | $ | 265 |  |  | $ | 2,661 |
Accumulated impairment losses |  |  |  |  |  | (291) |  |  | — |  |  | (773) |  |  | — |  |  | (1,064) |
Goodwill, net at December 31, 2024 |  |  |  |  |  | — |  |  | 829 |  |  | 503 |  |  | 265 |  |  | 1,597 |
Impairment |  |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Foreign Currency Translation |  |  |  |  |  | — |  |  | 10 |  |  | 19 |  |  | 6 |  |  | 35 |
Balance at March 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  | $ | 291 |  |  | $ | 839 |  |  | $ | 1,295 |  |  | $ | 271 |  |  | $ | 2,696 |
Accumulated impairment losses |  |  |  |  |  | $ | (291) |  |  | $ | — |  |  | $ | (773) |  |  | $ | — |  |  | $ | (1,064) |
Goodwill, net at March 31, 2025 |  |  |  |  |  | $ | — |  |  | $ | 839 |  |  | $ | 522 |  |  | $ | 271 |  |  | $ | 1,632 |
Identifiable definite-lived and indefinite-lived intangible assets were as follows:
|  | March 31, 2025 |  | December 31, 2024
(in millions) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Developed technology and patents |  | $ | 1,688 |  |  | $ | (1,146) |  |  | $ | 542 |  |  | $ | 1,639 |  |  | $ | (1,079) |  |  | $ | 560 |
Trade names and trademarks |  | 80 |  |  | (74) |  |  | 6 |  |  | 79 |  |  | (73) |  |  | 6 |
Licensing agreements |  | 43 |  |  | (29) |  |  | 14 |  |  | 29 |  |  | (28) |  |  | 1 |
Customer relationships |  | 1,049 |  |  | (755) |  |  | 294 |  |  | 1,019 |  |  | (716) |  |  | 303 |
Total definite-lived |  | 2,860 |  |  | (2,004) |  |  | 856 |  |  | 2,766 |  |  | (1,896) |  |  | 870 |
Indefinite-lived trade names and trademarks |  | 351 |  |  | — |  |  | 351 |  |  | 332 |  |  | — |  |  | 332 |
In-process R&D |  | 5 |  |  | — |  |  | 5 |  |  | 5 |  |  | — |  |  | 5 |
Total indefinite-lived |  | 356 |  |  | — |  |  | 356 |  |  | 337 |  |  | — |  |  | 337 |
Total identifiable intangible assets |  | $ | 3,216 |  |  | $ | (2,004) |  |  | $ | 1,212 |  |  | $ | 3,103 |  |  | $ | (1,896) |  |  | $ | 1,207 |
In the three months ended March 31, 2025, the Company acquired naming and certain other rights to a university dental laboratory in exchange for $14 million of equipment and consumable products to be transferred to the university through 2040. These rights were recorded as an intangible asset to be amortized over a fifteen-year period, with an offsetting contract liability that will be relieved as the products are provided to the university.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration